Literature DB >> 18551862

What do perceived cognitive problems reflect?

Catherine M Bender1, Maria L Pacella, Susan M Sereika, Adam M Brufsky, Victor G Vogel, Priya Rastogi, Frances E Casillo, Susan M Richey, Christopher M Ryan.   

Abstract

Women with breast cancer frequently report cognitive problems to healthcare providers during and after adjuvant therapy. Patients' perceptions of their cognitive problems would be expected to relate to objectively measured cognitive impairments. We explored the relationship between perceived cognitive function and objective ratings of thinking ability in early-stage breast cancer patients receiving hormonal therapy. In particular, we targeted objective measures of learning and memory as the primary endpoints in this exploratory study. We included a comprehensive battery of objective measures of cognitive function to explore relationships between perceived cognitive problems and impairments in other domains of cognitive function. At a minimum, our results indicated that women's complaints of cognitive problems should prompt additional assessment to clarify the bases of the problem and initiate appropriate intervention.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18551862      PMCID： PMC2833096     

Source DB:  PubMed          Journal:  J Support Oncol        ISSN： 1544-6794


  29 in total

1.  Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

Authors:  Tim A Ahles; Andrew J Saykin; Charlotte T Furstenberg; Bernard Cole; Leila A Mott; Karen Skalla; Marie B Whedon; Sarah Bivens; Tara Mitchell; E Robert Greenberg; Peter M Silberfarb
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

2.  Self-reports are not related to objective assessments of cognitive function and sedation in patients with cancer pain admitted to a palliative care unit.

Authors:  Pål Klepstad; Priscilla Hilton; Jorunn Moen; Bjørn Fougner; Petter C Borchgrevink; Stein Kaasa
Journal:  Palliat Med       Date:  2002-11       Impact factor: 4.762

3.  Cognitive dysfunction relates to subjective report of mental fatigue in patients with chronic fatigue syndrome.

Authors:  Lucile Capuron; Leonie Welberg; Christine Heim; Dieter Wagner; Laura Solomon; Dimitris A Papanicolaou; R Cameron Craddock; Andrew H Miller; William C Reeves
Journal:  Neuropsychopharmacology       Date:  2006-01-04       Impact factor: 7.853

4.  Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.

Authors:  Steven A Castellon; Patricia A Ganz; Julienne E Bower; Laura Petersen; Laura Abraham; Gail A Greendale
Journal:  J Clin Exp Neuropsychol       Date:  2004-10       Impact factor: 2.475

5.  Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.

Authors:  Helen G Mar Fan; Nadine Houédé-Tchen; Qi-Long Yi; Irene Chemerynsky; Fiona P Downie; Kathryn Sabate; Ian F Tannock
Journal:  J Clin Oncol       Date:  2005-11-01       Impact factor: 44.544

6.  Cognitive impairment associated with adjuvant therapy in breast cancer.

Authors:  Catherine M Bender; Susan M Sereika; Sarah L Berga; Victor G Vogel; Adam M Brufsky; Karen K Paraska; Christopher M Ryan
Journal:  Psychooncology       Date:  2006-05       Impact factor: 3.894

Review 7.  Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients--evaluation of appropriate research design and methodology to measure symptoms.

Authors:  Tomohiro Matsuda; Tomoko Takayama; Manabu Tashiro; Yu Nakamura; Yasuo Ohashi; Kojiro Shimozuma
Journal:  Breast Cancer       Date:  2005       Impact factor: 4.239

8.  Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen.

Authors:  A Paganini-Hill; L J Clark
Journal:  Breast Cancer Res Treat       Date:  2000-11       Impact factor: 4.872

Review 9.  Are memory complaints predictive for dementia? A review of clinical and population-based studies.

Authors:  C Jonker; M I Geerlings; B Schmand
Journal:  Int J Geriatr Psychiatry       Date:  2000-11       Impact factor: 3.485

10.  A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer.

Authors:  V Jenkins; V Shilling; G Deutsch; D Bloomfield; R Morris; S Allan; H Bishop; N Hodson; S Mitra; G Sadler; E Shah; R Stein; S Whitehead; J Winstanley
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640
View more
  14 in total

1.  Impact of increasing physical activity on cognitive functioning in breast cancer survivors: Rationale and study design of Memory & Motion.

Authors:  Sheri J Hartman; Loki Natarajan; Barton W Palmer; Barbara Parker; Ruth E Patterson; Dorothy D Sears
Journal:  Contemp Clin Trials       Date:  2015-09-30       Impact factor: 2.226

2.  Influence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancer.

Authors:  Catherine M Bender; Amanda L Gentry; Adam M Brufsky; Frances E Casillo; Susan M Cohen; Meredith M Dailey; Heidi S Donovan; Jacqueline Dunbar-Jacob; Rachel C Jankowitz; Margaret Q Rosenzweig; Paula R Sherwood; Susan M Sereika
Journal:  Oncol Nurs Forum       Date:  2014-05       Impact factor: 2.172

3.  Cognitive function after the initiation of adjuvant endocrine therapy in early-stage breast cancer: an observational cohort study.

Authors:  Patricia A Ganz; Laura Petersen; Steven A Castellon; Julienne E Bower; Daniel H S Silverman; Steven W Cole; Michael R Irwin; Thomas R Belin
Journal:  J Clin Oncol       Date:  2014-09-29       Impact factor: 44.544

4.  Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.

Authors:  Patricia A Ganz; Lorna Kwan; Steven A Castellon; Amy Oppenheim; Julienne E Bower; Daniel H S Silverman; Steve W Cole; Michael R Irwin; Sonia Ancoli-Israel; Thomas R Belin
Journal:  J Natl Cancer Inst       Date:  2013-04-19       Impact factor: 13.506

5.  Trajectories of self-reported cognitive function in postmenopausal women during adjuvant systemic therapy for breast cancer.

Authors:  John D Merriman; Susan M Sereika; Adam M Brufsky; Priscilla F McAuliffe; Kandace P McGuire; Jamie S Myers; Mary L Phillips; Christopher M Ryan; Amanda L Gentry; Lindsay D Jones; Catherine M Bender
Journal:  Psychooncology       Date:  2015-10-20       Impact factor: 3.894

6.  Psychometric analysis of the Patient Assessment of Own Functioning Inventory in women with breast cancer.

Authors:  Mandy J Bell; Lauren Terhorst; Catherine M Bender
Journal:  J Nurs Meas       Date:  2013

7.  Cognitive and Occupational Function in Survivors of Adolescent Cancer.

Authors:  Bethany D Nugent; Catherine M Bender; Susan M Sereika; Jean M Tersak; Margaret Rosenzweig
Journal:  J Adolesc Young Adult Oncol       Date:  2017-08-07       Impact factor: 2.223

8.  Trajectories of Cognitive Function and Associated Phenotypic and Genotypic Factors in Breast Cancer.

Authors:  Catherine M Bender; John D Merriman; Susan M Sereika; Amanda L Gentry; Frances E Casillo; Theresa A Koleck; Margaret Q Rosenzweig; Adam M Brufsky; Priscilla McAuliffe; Yehui Zhu; Yvette P Conley
Journal:  Oncol Nurs Forum       Date:  2018-05-01       Impact factor: 2.172

9.  Validation of the Chinese Version of the Cognitive Symptom Checklist-Work-21 in Breast Cancer Survivors.

Authors:  Andy S K Cheng; Yingchun Zeng; Michael Feuerstein
Journal:  J Occup Rehabil       Date:  2015-12

Review 10.  Can Exercise Ameliorate Aromatase Inhibitor-Induced Cognitive Decline in Breast Cancer Patients?

Authors:  Cuicui Li; Chenglin Zhou; Rena Li
Journal:  Mol Neurobiol       Date:  2015-07-30       Impact factor: 5.590
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.